BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29428106)

  • 1. Efficacy of octreotide in the prevention of complications after pancreaticoduodenectomy in patients with soft pancreas and non-dilated pancreatic duct: A prospective randomized trial.
    El Nakeeb A; ElGawalby A; A Ali M; Shehta A; Hamed H; El Refea M; Moneer A; Abd El Rafee A
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):59-63. PubMed ID: 29428106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic octreotide and delayed gastric emptying after pancreaticoduodenectomy: results of a prospective randomized double-blinded placebo-controlled trial.
    Kollmar O; Moussavian MR; Richter S; de Roi P; Maurer CA; Schilling MK
    Eur J Surg Oncol; 2008 Aug; 34(8):868-875. PubMed ID: 18299182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide Does Not Prevent Pancreatic Fistula Following Pancreatoduodenectomy in Patients with Soft Pancreas and Non-dilated Duct: A Prospective Randomized Controlled Trial.
    Kurumboor P; Palaniswami KN; Pramil K; George D; Ponnambathayil S; Varma D; Aikot S
    J Gastrointest Surg; 2015 Nov; 19(11):2038-44. PubMed ID: 26302879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors of pancreatic leakage after pancreaticoduodenectomy.
    Yang YM; Tian XD; Zhuang Y; Wang WM; Wan YL; Huang YT
    World J Gastroenterol; 2005 Apr; 11(16):2456-61. PubMed ID: 15832417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled study of the effect of octreotide on pancreatic exocrine secretion and pancreatic fistula after pancreatoduodenectomy.
    You DD; Paik KY; Park IY; Yoo YK
    Asian J Surg; 2019 Feb; 42(2):458-463. PubMed ID: 30262436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide does not prevent postoperative pancreatic fistula or mortality following Pancreaticoduodenectomy.
    Barnett SP; Hodul PJ; Creech S; Pickleman J; Arahna GV
    Am Surg; 2004 Mar; 70(3):222-6; discussion 227. PubMed ID: 15055845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease.
    Lowy AM; Lee JE; Pisters PW; Davidson BS; Fenoglio CJ; Stanford P; Jinnah R; Evans DB
    Ann Surg; 1997 Nov; 226(5):632-41. PubMed ID: 9389397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of octreotide on pancreatic fistula after pancreaticoduodenectomy: a prospective study].
    Kong R; Hu J; Li L; Wang G; Chen H; Bai X; Wang Y; Wu L; Jiang H; Sun B
    Zhonghua Wai Ke Za Zhi; 2016 Jan; 54(1):21-4. PubMed ID: 26792348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective randomized trial of the effect of octreotide on pancreatic juice output after pancreaticoduodenectomy in relation to histological diagnosis, duct size and leakage.
    Fernández-Cruz L; Jiménez Chavarría E; Taurà P; Closa D; Boado MA; Ferrer J
    HPB (Oxford); 2013 May; 15(5):392-9. PubMed ID: 23557411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study between duct to mucosa and invagination pancreaticojejunostomy after pancreaticoduodenectomy: a prospective randomized study.
    El Nakeeb A; El Hemaly M; Askr W; Abd Ellatif M; Hamed H; Elghawalby A; Attia M; Abdallah T; Abd ElWahab M
    Int J Surg; 2015 Apr; 16(Pt A):1-6. PubMed ID: 25682724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of prophylactic long-acting octreotide in high-risk patients undergoing pancreaticoduodenectomy.
    Graham JA; Johnson LB; Haddad N; Al-Kawas F; Carroll J; Jha R; Wong J; Maglaris D; Mertens S; Fishbein T
    Am J Surg; 2011 Apr; 201(4):481-5. PubMed ID: 21421102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of risk factors for postoperative pancreatic fistula following pancreaticoduodenectomy.
    Liu QY; Zhang WZ; Xia HT; Leng JJ; Wan T; Liang B; Yang T; Dong JH
    World J Gastroenterol; 2014 Dec; 20(46):17491-7. PubMed ID: 25516663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized multicentre trial comparing external and internal pancreatic stenting during pancreaticoduodenectomy.
    Jang JY; Chang YR; Kim SW; Choi SH; Park SJ; Lee SE; Lim CS; Kang MJ; Lee H; Heo JS
    Br J Surg; 2016 May; 103(6):668-675. PubMed ID: 27040594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide and postoperative pancreatic fistula after pancreaticoduodenectomy: What we know so far? A narrative review.
    Tilak M; Tewari M; Shukla HS
    Indian J Cancer; 2023; 60(2):152-159. PubMed ID: 37530235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary leakage following pancreaticoduodenectomy: Prevalence, risk factors and management.
    El Nakeeb A; El Sorogy M; Hamed H; Said R; Elrefai M; Ezzat H; Askar W; Elsabbagh AM
    Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):67-72. PubMed ID: 30413347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial.
    Yeo CJ; Cameron JL; Lillemoe KD; Sauter PK; Coleman J; Sohn TA; Campbell KA; Choti MA
    Ann Surg; 2000 Sep; 232(3):419-29. PubMed ID: 10973392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide prophylaxis is not beneficial for biochemical activity and clinical severity of postoperative pancreatic fistula after pancreatic surgery.
    Droeser RA; Jeanmonod P; Schuld J; Moussavian MR; Schilling MK; Kollmar O
    Dig Surg; 2012; 29(6):484-91. PubMed ID: 23392293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial.
    Winter JM; Cameron JL; Campbell KA; Chang DC; Riall TS; Schulick RD; Choti MA; Coleman J; Hodgin MB; Sauter PK; Sonnenday CJ; Wolfgang CL; Marohn MR; Yeo CJ
    J Gastrointest Surg; 2006 Nov; 10(9):1280-90; discussion 1290. PubMed ID: 17114014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailored pancreatic reconstruction after pancreaticoduodenectomy: a single-center experience of 892 cases.
    El Nakeeb A; Sultan AM; Atef E; Salem A; Abu Zeid M; Abu El Eneen A; El Ebidy G; Abdel Wahab M
    Hepatobiliary Pancreat Dis Int; 2017 Oct; 16(5):528-536. PubMed ID: 28992886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk scoring system and predictor for clinically relevant pancreatic fistula after pancreaticoduodenectomy.
    Chen JY; Feng J; Wang XQ; Cai SW; Dong JH; Chen YL
    World J Gastroenterol; 2015 May; 21(19):5926-33. PubMed ID: 26019457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.